(a) Schematic of the in vitro heme attachment reaction of HCCS with apocytochrome c (apocyt c). Mitochondrial cyt c synthase, HCCS, positions heme (orange) and attaches it to apocyt c. Cyt c is …
(a) Heme c synthesis (one vinyl group shown with one thiol of CXXCH): cys thiol attachment to carbon of the vinyl group of heme. (b) schematic of the reaction that takes place between apocyt c …
WT (blue, n = 7) and H154A (orange, n = 3). Exogenous heme at indicated concentration (x-axis) was added to GST-HCCS during batch purification with glutathione agarose for 20 hr. GST-HCCS was …
(a) The reaction of 10 µM HCCS and 20 µM apocyt c (initial, black) was initiated with 5 mM DTT and incubated for 1 hr at 37°C (red, final). The inset shows the pyridine hemochrome assay spectra …
Aerobic reaction with 3 µM HCCS (+HL) and 20 µM apocyt c were initiated with 3 mM DTT and monitored over a period of 4 hr at the indicated time points and temperatures. Cyt c biosynthesis was …
(a) 0 mM, (b) 0.1 mM, (c) 1 mM, and (d) 3 mM DTT were added to a reaction of 3 µM HCCS and 6.5 µM apocyt c. Cyt c biosynthesis was monitored by appearance of a 550 nm peak. The initial (black) …
(a) As in Figure 1b, apocyt c and HCCS (± HL) were combined (black). The reaction was initiated with 5 mM DTT and allowed to react for 1 hr at 37°C (red). HCCS matured apocyt c, while HCCS H154A did …
(a) Four-step model of HCCS function. UV–vis spectra corresponding to each step are shown. Step 1, HCCS binds to heme via residue H154. Step 2, HCCS binds to apocyt c and His19 (of CXXCH) forms the …
(a) Schematic of HCCS released product assay. In vitro reaction is carried out with bead tethered GST-HCCS. Centrifugation separates the beads (GST-HCCS) and supernatant (e.g. released products). (b)…
(a) Sequence of three CXXCH containing peptides with alpha helix 1 and CXXCH designated. Three-dimensional structures of peptides with heme were generated from the cyt c 3D crystal structure PDB: …
(a) In vitro assay was performed with HCCS with the labeled peptides. The final UV–vis heme spectra is shown. A peak at 550–555 nm indicates that heme has covalently bound to cyt c peptide. Peaks at …
ImageJ Pixel analysis of heme stained bands.
C15S refers to Cys15Ser; DC15 refers to Cys15 D-Cys15 replacing L-Cys15; HoC15 refers to homocysteine replacing L-Cys15. (a) Heme stain and Coomassie showing that 20mer peptides WT (lane 2), C15S …
(a) Release assay as in Figure 4b. Briefly, C15S 20mer is added to HCCS bound to glutathione agarose (beads) and reacted for 1 hr. Heme staining shows that the majority of matured C15S 20mer remains …
Summary of percent released substrate.
(a) The 20mer reaction was analyzed by SEC-HPLC (blue) and compared to HCCS alone (brown). The ‘heme attached peptide’ serves as a positive control for a released peptide (green). It is commercially …
(a) Schematics of CcsBA constructs used for overexpression and affinity purification. Gray, GST ORF; red, ccsB; blue ccsA; purple, C-terminal 6XHis tag. Site of natural proteolysis is shown with …
(a) Schematic of the heme attachment reaction of CcsBA with apocyt c. Note, CcsBA has two heme binding sites, one in the periplasmic WWD domain (P-heme site, orange heme) and one in the …
Peptides are described in Figure 3a. (a) Ten micromolar of CcsBA was incubated with 20 µM of the indicated peptide for 3 hr. Samples were taken at 0 and 3 hr and separated by Tris–tricine SDS–PAGE. …
(a) In vitro assay was performed with CcsBA with the indicated peptides. The final UV–vis heme spectra is shown. A peak at 550–555 nm indicates that heme has covalently bound to cyt c peptide. Peaks …
Image J Pixel analysis of heme-stained bands.
(a) Heme and coomassie stain of anaerobic in vitro reactions of CcsBA and HCCS showing that CcsBA matures the 20, 16, and 11mers, while HCCS matures the 16 and 20mers under the same conditions at 3 …
C15S refers to Cys15Ser; DC15 refers to Cys15 d-Cys15 replacing l-Cys15; HoC15 refers to homocysteine replacing l-Cys15. (a) Heme stain of CcsBA and CXXCH variant 20mer peptides (red) showing that …
HCCS | CcsBA | |||||||
---|---|---|---|---|---|---|---|---|
Peptide name | Peptide sequence | Attachment | α-Peak (nm) | # cov attachments** |
Attachment | α-Peak (nm) | # cov attachments** |
|
![]() |
Minimal recognition primary/secondary sequences (lengths) | |||||||
HH Cyt c | …GDVEKGKKIFVQK TVE AQ H… | Attached | 550 | 2 | Attached | 550, 560 | 2 | |
56-mer | GDVEKGKKIFIMK TVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKG SQ H | Attached | 555 | 2 | Attached | 550, 560 | 2 | |
20 mer | GDVEKGKKIFIMK TV SQ H | Attached | 553–554 | 2*** | Attached | 550, 560 | 2 | |
16 mer | KGKKIFIMK TV SQ H | Attached | 552 | 2 | Attached | 551, 560 | 2 | |
11 mer | IMK TVE SQ H | Not attached | 559 | 0 | Attached | 550, 560 | 2 | |
nine mer | K TVE SQ H | Not attached | 559 | 0 | Attached | 550, 560 | 2 | |
Cysteine substitutions | ||||||||
20 mer Cys15S | GDVEKGKKIFIMK TV SQ H | Attached | 555,559.5 | 1*** | Not attached | n.a. | 0 | |
20 mer DCys15 | GDVEKGKKIFIMK(TV )SQ H | Attached | 555 | 2*** | Not attached | 560 | 0 | |
20 mer HoCys15 | GDVEKGKKIFIMK TV SQ H | Attached | 555 | 1*** | Attached | 550, 560 | 2 | |
20 mer Cys18S | GDVEKGKKIFIMK TV SQ H | Attached | 559 | 1*** | Not attached | 560 | 0 | |
20 mer DCys18 | GDVEKGKKIFIMK TV SQ( H | Attached | 554 | 1*** | Not attached | 560 | 0 | |
20 mer HoCys18 | GDVEKGKKIFIMK TV SQ H | Attached | 558 | 1*** | Not attached | 560 | 0 | |
20 mer Cys15S/Cys18S | GDVEKGKKIFIMK TV SQ H | Not attached | 559 | 0 | Not attached | 560 | 0 | |
Histidine (of CXXCH) and lysine (K→D) substitutions for testing interaction models | ||||||||
20mer H19A | GDVEKGKKIFIMK TV SQ A | Not attached | 560 | 0 | Not attached | 560 | 0 | |
20mer H19M | GDVEKGKKIFIMK TV SQ M | Attached | 559 | 2 | Not attached | 560 | 0 | |
20mer H19K | GDVEKGKKIFIMK TV SQ K | Not attached | 560 | 0 | Not attached | 560 | 0 | |
20mer K6A, K8D, K9D, K14D | GDVEAGDDIFIMD TV SQ H | Not attached | 560 | 0 | Not attached | 560 | 0 |
*Supplementary file 2 contains additional information about peptides, eg. purity, synthesis co, and presence or absence of an N-terminal biotin-AHX tag.
**Number of covalent attachments determined by the final reaction spectra absorbance blue shifted from 560 nm and the presence of a heme stainable peptide.
***Pyridine hemochrome was performed to determine this number.
Reagent type (species) or resource |
Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Escherichia coli) | NEB 5-α | New England Biolabs | fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 | Electrocompetent cells |
Strain, strain background (E. coli) | C43(DE3) | doi:10.1006/jmbi.1996.0399; Miroux and Walker, 1996 | F – ompT hsdSB (rB- mB-) gal dcm (DE3) | Electrocompetent cells |
Strain, strain background (E. coli) | RK103 | doi:10.1111/j.1365–2958.2006.05132.x | MG1655 Δccm::kanR , deleted for all ccm genes | Electrocompetent cells, protein expression, functional assays |
Strain, strain background (E. coli) | MS36 | doi:10.1128/mBio.02134–18 | C43 Δccm::kanR , deleted for all ccm genes | Electrocompetent cells, protein expression, functional assays |
Antibody | Anti-equine heart cytochromec (Rabbit polyclonal) | doi:10.1074/jbc.M116.741231 | (1:10,000) | |
Recombinant DNA reagent | pRGK332 (plasmid) | doi:10.1111/j.1365–2958.2006.05132.x | pBAD Bordetella pertussis cytochrome c4:His | |
Recombinant DNA reagent | pRGK368 (plasmid) | doi:10.1128/JB.01388–06; Richard-Fogal et al., 2007 | pGEX Helicobacter hepaticus GST:CcsBA | |
Recombinant DNA reagent | pRGK403 (plasmid) | doi:10.1073/pnas.1213897109 | pGEX GST:HCCS | |
Recombinant DNA reagent | pRGK420 (plasmid) | doi:10.1073/pnas.1213897109 | pGEX GST:HCCS H154A | |
Recombinant DNA reagent | pMCS97 (plasmid) | This study | pGEX H. hepaticus GST:CcsBA:His | See Materials and Methods and Supplementary file 1 |
Recombinant DNA reagent | pMCS64 (plasmid) | This study | pGEX H. hepaticus GST*CcsBA:His | See Materials and Methods and Supplementary file 1 |
Recombinant DNA reagent | pMCS154 (plasmid) | doi:10.1128/mBio.02134–18 | pGEX H. hepaticus GST:CcsBA:His | |
Recombinant DNA reagent | pMCS558 (plasmid) | This study | pGEX H. hepaticus *CcsBA:His | See Materials and Methods and Supplementary file 1 |
Recombinant DNA reagent | MCS598 (plasmid) | This study | pGEX H. hepaticus GST*CcsBA:His P-His1/2G | See Materials and Methods and Supplementary file 1 |
Sequence-based reagent | pGEX GST*F | This study | PCR Primer | tcggatctggttccgcgttgaaggaggaaggatccatgatgaat |
Sequence-based reagent | pGEX GST*R | This study | PCR Primer | attcatcatggatccttcctccttcaacgcggaaccagatccga |
Sequence-based reagent | pGEX CcsBA 6HisF | This study | PCR Primer | gagtgcttgatatgccccatttacatcaccatcaccatcactaactcgagcggc |
Sequence-based reagent | pGEX CcsBA 6HisR | This study | PCR Primer | gccgctcgagttagtgatggtgatggtgatgtaaatggggcatatcaagcactc |
Sequence-based reagent | MSP5 | This study | PCR Primer | gtgcttaaatcttattggctcaacattggcgtctccgtcatca |
Sequence-based reagent | MSP6 | This study | PCR Primer | tgatgacggagacgccaatgttgagccaataagatttaagcac |
Sequence-based reagent | MSP7 | This study | PCR Primer | ttattatctcacaggtatgggcagctatgccgcaggagaa |
Sequence-based reagent | MSP8 | This study | PCR Primer | ttctcctgcggcatagctgcccatacctgtgagataataa |
Peptide, recombinant protein | Holo-MP11 | Sigma-Aldrich | Cat. #M6756 | See Supplementary file 2 |
Peptide, recombinant protein | Biotin-56-mer | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | Biotin-20 mer | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 20-mer | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | Biotin-16 mer | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 11 mer | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | nine mer-biotin | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer Cys15S | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer DCys15 | CS Bio Co | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer HoCys15 | CS Bio Co | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer Cys18S | CS Bio Co | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer DCys18 | CS Bio Co | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer HoCys18 | CS Bio Co | See Supplementary file 2 | |
Peptide, recombinant protein | 20 mer Cys15S/Cys18S | CS Bio Co | See Supplementary file 2 | |
Peptide, recombinant protein | 20mer H19A | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 20mer H19M | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 20mer H19K | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | 20mer K6A, K8D, K9D, K14D | RS-synthesis | See Supplementary file 2 | |
Peptide, recombinant protein | Pierce-glutathione agarose | Thermo Scientific | Cat. #16101 | |
Peptide, recombinant protein | Talon Resin | TaKaRa | Cat. #635503 | |
Chemical compound, drug | Hematin | Fisher | Cat. #AAA1851803 | |
Chemical compound, drug | N, N, N’, N’-tetramethylbenzidine (TMBZ) | Sigma | Cat. #1086220001 | |
Chemical compound, drug | Equine horse-heart cytochrome c | Sigma | Cat. #C2506 | |
Chemical compound, drug | 2,6-dichloroindophenolate hydrate (DCPIP) | Sigma | Cat. #D-1878 | |
Commercial assay or kit | Pierce-SuperSignal West Femto ECL reagent | Thermo Scientific | Cat. #PI34096 |
Relevant strains, plasmids, and primers.
Apo peptides used for in vitro assays.